Montevideo, Uruguay

Carlos Escande

This inventor holds 7 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Institut Pasteur De Montevideo, University of the Republic, Other. Active years: 2018-2025.

USPTO Granted Patents = 7 

% Patents Active = 85.7


 

Average Co-Inventor Count = 8.2

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Carlos Escande

Introduction: Carlos Escande is a visionary inventor hailing from Montevideo, Uruguay. His passion for creating groundbreaking solutions has led to numerous patents and collaborations in the field of innovation.

Latest Patents: Carlos Escande's latest patents include cutting-edge technologies in renewable energy, sustainable agriculture, and advanced healthcare devices. His inventions have been recognized for their impact on improving lives and the environment.

Career Highlights: With a career spanning over two decades, Carlos Escande has established himself as a leading figure in the world of innovation. His dedication to pushing the boundaries of what is possible has resulted in a diverse portfolio of patents that have revolutionized various industries.

Collaborations: Throughout his career, Carlos Escande has collaborated with top research institutions, universities, and companies worldwide. His ability to work across disciplines and bring together experts from different fields has been instrumental in the success of his innovative projects.

Conclusion: Carlos Escande's relentless pursuit of innovation and his commitment to creating a better future through his inventions make him a true pioneer in the world of technology. His impact on society and the environment serves as an inspiration for aspiring inventors around the globe.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…